Clinical Trials on FMR1-related Primary Ovarian Insufficiency

Total 15495 results

City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer

Platinum-Resistant Ovarian Carcinoma

United States
University Health Network, Toronto

Completed

18F-DCFPyL PET/CT in High-grade Epithelial Ovarian Cancer (PET HOC)

Stage IV Ovarian Cancer | Stage III Ovarian Cancer

Canada
SOTIO a.s.

Completed

Phase II Study DCVAC/OvCa Added to First Line Carboplatin and Paclitaxel Newly Diagnosed Epithelial Ovarian Carcinoma

Ovarian Neoplasms | Ovarian Epithelial Cancer

Czechia, Poland
Yonsei University
National Cancer Center, Korea; Samsung Medical Center; AstraZeneca; Seoul National... and other collaborators

Unknown

A Phase II Study of Neoadjuvant Chemotherapy Plus Durvalumab (MEDI4736) and Tremelimumab in Advanced-stage Ovarian Cancer (TRU-D) (KGOG3046)

Ovarian Cancer Stage IIIC | Ovarian Cancer Stage IV

Korea, Republic of
Hospices Civils de Lyon

Recruiting

NIRAPK : Study of the Relationship(s) Between Clinical, Biological and Pharmacokinetic Metrics and Toxicities When Niraparib is Used as Maintenance Treatment for Ovarian Cancer Patients. (NIRAPK)

Adult Patients With Platinum-sensitive, Relapsed, High Grade Serous Epithelial Ovarian Cancer

France
San Carlo Public Hospital, Potenza, Italy

Completed

Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS

Ovarian Hyperstimulation Syndrome

Italy
Royan Institute

Completed

Compare the Efficacy of Human Albumin With Cabergoline to Prevent Ovarian Hyper Stimulation in Assisted Reproductive Technology (ART) Program

Ovarian Hyperstimulation Syndrome

Iran, Islamic Republic of
Iakentro Fertility Centre
Aristotle University Of Thessaloniki

Completed

Double GnRH Antagonist Daily Dose in Hyperresponding IVF/ICSI Cycles May Prevent the OHSS

Ovarian Hyperstimulation Syndrome
University of Connecticut
Organon

Completed

The Use of GnRH Agonist Trigger in the Prevention of OHSS

Ovarian Hyperstimulation Syndrome

United States
University of Saskatchewan

Not yet recruiting

Effect of Intravenously Iron Infusion on the Prevention and Treatment of Anemia in Ovarian Cancer

Anaemia in Ovarian Carcinoma

Canada
GeneScience Pharmaceuticals Co., Ltd.
The First Affiliated Hospital with Nanjing Medical University; The First Affiliated... and other collaborators

Unknown

Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET

Ovarian Hyperstimulation Syndrome

China
CHA University

Recruiting

Comparison of Clinical Outcomes Between IVM and Minimal Stimulation IVF in Patients With PCOS

No Condition

Korea, Republic of
Assiut University

Unknown

The Efficacy of Progestins in Treatment of Functional Ovarian Cyst

Functional Ovarian Cyst | Progesterone
Diurnal Limited

Completed

Chronocort Versus Plenadren Replacement Therapy in Adults With Adrenal Insufficiency (CHAMPAIN)

Primary Adrenal Insufficiency

Germany, United Kingdom
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

Ovarian Clear Cell Cystadenocarcinoma | Ovarian Serous Cystadenocarcinoma | Fallopian Tube Carcinoma | Endometrial Adenocarcinoma | Primary Peritoneal Carcinoma | Malignant Ovarian Mixed Epithelial Tumor | Ovarian Brenner Tumor | Ovarian Mucinous Cystadenocarcinoma | Undifferentiated Ovarian Carcinoma | Gastrointestinal Complication and other conditions

United States
Grupo Español de Investigación en Cáncer de Ovario
Roche Pharma AG

Terminated

Neoadjuvant Therapy in Advanced Ovarian Cancer With Avastin (NOVA)

Cancer, Ovarian

Spain
Imperial College London
GlaxoSmithKline

Completed

[18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer (PAZPET-1)

Ovarian Neoplasm

United Kingdom
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Paclitaxel and Carboplatin Combination as 1st Line Treatment in Ovarian Carcinomas

Ovarian Cancer

Greece
Impact Therapeutics, Inc.

Completed

The Safety and Pharmacokinetics of IMP4297 in Patients With Advanced Solid Tumors

Breast Cancer | Ovarian Cancer | Prostate Cancer | Primary Peritoneal Cancer | Advanced Solid Tumours

Australia
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Qilu Hospital of Shandong University; Yunnan Cancer Hospital

Not yet recruiting

Effect of Sodium Thiosulfate on Nephrotoxicity of Cisplatin Intraperitoneal Heat-perfusion Chemotherapy

Epithelial Ovarian Cancer | Acute Kidney Injury Due to Circulatory Failure
National Cancer Institute, Naples

Active, not recruiting

Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian Cancer (MITO-7)

Ovarian Cancer

Italy
Seoul National University Hospital
Pharos iBio Co., Ltd.

Recruiting

Chk2 Inhibitor for Recurrent EpitheliAl periToneal, fallopIan or oVarian cancEr (CREATIVE Phase IA Trial) (CREATIVE)

Platinum-resistant Ovarian Cancer | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-refractory Ovarian Carcinoma

Korea, Republic of
Gynecologic Oncology Group
National Cancer Institute (NCI)

Not yet recruiting

Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199

Fallopian Tube Carcinoma | Ovarian Carcinoma | Hereditary Breast and Ovarian Cancer Syndrome | Primary Peritoneal Carcinoma

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI); Merck Sharp & Dohme LLC; Celldex Therapeutics

Recruiting

Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Endometrial Serous Adenocarcinoma | Ovarian Clear Cell Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Platinum-Sensitive Ovarian Carcinoma | Recurrent Fallopian... and other conditions

United States
National Cancer Institute, Naples

Recruiting

MITO 35a: Olaparib Maintenance Therapy in Newly Diagnosed BRCA Wild-type Advanced Ovarian, Fallopian Tube and Primitive Peritoneal Cancer (MITO 35a)

Ovarian Cancer

Italy
University Hospital, Toulouse

Recruiting

Pubertal Evolutionary Profile of Children Monitored for Fetal Ovarian Cyst (KOF)

Fetal Ovarian Cyst

France
Assiut University

Recruiting

Letrozole in Clomiphene Resistant Infertile Women With Polycystic Ovarian Syndrome

Infertility, Female

Egypt
Kangbuk Samsung Hospital

Recruiting

KOrean Borderline Ovarian Tumor (KOBOT) Registry (KOBOT)

Ovarian Neoplasms

Korea, Republic of
Alexandria University

Active, not recruiting

VATS IN PATIENTS WITH ADVANCED OVARIAN MALIGNANCIES

Ovarian Cancer

Egypt
BerGenBio ASA

Terminated

A Study of Tilvestamab (BGB149) in Relapsed, Platinum-resistant, High-grade Serous Ovarian Cancer (HGSOC) Participants

Ovarian Neoplasms

Korea, Republic of, Singapore, United Kingdom, Norway
Royan Institute

Completed

The Four Methods of Ovarian Stimulation in Patients With Polycystic Ovarian Syndrome

Polycystic Ovary Syndrome | Ovarian Hyperstimulation Syndrome

Iran, Islamic Republic of
AstraZeneca

Completed

FLABRA: Frontline Approach for BRCA Testing in OC Treatment naïve Population. A LATIN AMERICA Epidemiologic Study (FLABRA)

Ovarian Cancer

Brazil, Panama, Colombia, Argentina, Mexico, Peru
Bruce Lessey

Terminated

Efficacy Study of Raloxifene to Induce Ovulation in Polycystic Ovarian Syndrome (PCOS)

Polycystic Ovarian Syndrome

United States
Ain Shams University

Unknown

The Impact of Electrocoagulation on Ovarian Reserve After Laparoscopic Excision of Ovarian Cysts.

Ovarian Endometrioma | Ovary Cyst

Egypt
University of California, Davis
National Institutes of Health (NIH); National Center for Complementary and...

Completed

Compare Effects of Flax Seed Oil, and Fish Oil on Blood Sugar Levels (PCOS)

Polycystic Ovarian Syndrome

United States
Boehringer Ingelheim

Completed

A Randomised Placebo-Controlled Phase II Study of Continuous Maintenance Treatment With BIBF 1120 Following Chemotherapy in Patients With Relapsed Ovarian Cancer

Ovarian Neoplasms

United Kingdom
Maastricht University Medical Center

Completed

MR-PET for Staging and Assessment of Operability in Ovarian Cancer - a Feasibility Study

Ovarian Neoplasms

Netherlands
HaEmek Medical Center, Israel
Women and Infants Hospital of Rhode Island

Withdrawn

Prediction of Ovarian Malignancy in the Presence of Sonographic Pelvic Mass

Ovarian Neoplasm

Israel
GlaxoSmithKline

Completed

Efficacy and Safety of Pazopanib Monotherapy After First-line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Asian Women

Neoplasms, Ovarian

Taiwan, Hong Kong, China, Korea, Republic of
Kufa University

Completed

Clomiphene Stair-Step Protocol for Ovulation Induction in Women With Polycystic Ovarian Syndrome (PCOSCCTvUSS)

Polycystic Ovary Syndrome

Iraq
Chinese PLA General Hospital

Completed

Elecsys HE4 Chinese Reference Value Study

Ovarian Cancer

China
Duke University

Terminated

Polycystic Ovarian Syndrome: Impact of Flaxseed Supplementation

Polycystic Ovarian Syndrome

United States
Zagazig University

Completed

Study to Compare Between Combimed Metformin-letrozole and Ovarian Drilling in Pcos With Bilateral Ovarian Drilling in Clomiphene-resistant Infertile Women With Polycystic Ovarian Syndrome

Focus of Study

Egypt
Sanofi

Completed

Docetaxel and Carboplatin as First-line Chemotherapy in Early Stage as Well as Advanced or Metastatic Ovarian Cancer (OCSTUD)

Ovarian Neoplasms

Bangladesh
Telik

Completed

TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer

Ovarian Neoplasms

United States
ARCAGY/ GINECO GROUP

Completed

French Observatory of Rare Malignant Tumors of the Ovary

Ovarian Tumors

France
V.K.V. American Hospital, Istanbul

Unknown

Comparison of Bone Morphogenetic Protein-4 (BMP-4) and 7 Levels Between Control and Polycystic Ovarian Syndrome (PCOS) Patients.

Polycystic Ovarian Syndrome

Turkey
Yunyang Medical College

Unknown

Letrozole Combined With Gonadotropins (Gn) for Ovarian Stimulation Undergoing in Vitro Fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI) in Patients With Polycystic Ovary Syndrome (PCOS)

Polycystic Ovarian Syndrome

China
Sheba Medical Center

Completed

In Vitro Maturation of Immature Oocytes

Polycystic Ovary Syndrome | Ovarian Hyperstimulation Syndrome

Israel
CTI BioPharma

Completed

Phase II CT-2103/Carboplatin in Ovarian Cancer

Ovarian Neoplasm

United States

Clinical Trials on FMR1-related Primary Ovarian Insufficiency

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations